Tu1749 POST-USTEKINUMAB INDUCTION IL-12, IL-23, AND USTEKINUMAB LEVELS ARE ASSOCIATED WITH CLINICAL RESPONSE IN A MULTICENTRE PROSPECTIVE COHORT STUDY OF CROHN'S DISEASE PATIENTS: RESULTS FROM THE AURORA STUDY
Yoon‐Kyo An(Mater Hospital), Jakob Begun(Translational Research Institute), Niamh Lindsay(Mater Research), Kam‐Fai Wong(Peking University), Astrid‐Jane Williams, Daniel Lightowler(The University of Western Australia), Peter De Cruz(The University of Melbourne), Anna Amiss(Mater Research), Graham Radford‐Smith(QIMR Berghofer Medical Research Institute), Rupert W. Leong(The University of Sydney), Britt Christensen(The Royal Melbourne Hospital), Kavitha Subramaniam(Australian National University), Daniel R. van Langenberg(Eastern Health), Jane M. Andrews(Health Net), Simon Ghaly(UNSW Sydney), Lena Thin(The University of Western Australia), C Li Wai Suen(The University of Melbourne), Susan J. Connor(Liverpool Hospital), Hai Pham(QIMR Berghofer Medical Research Institute), Viraj C. Kariyawasam(Concord Repatriation General Hospital), Nikola Mitrev(Blacktown & Mount Druitt Hospital), Nik S. Ding(The University of Melbourne), Richard Fernandes(The University of Queensland), Emi Khoo(The University of Queensland), Miles Sparrow(Alfred Health), Lauren S. White, Natalie Allan(Mater Research), Robert V. Bryant(Queen Elizabeth Hospital), Soong-Yuan Ooi, Hansjoerg Seltenreich(University of the Sunshine Coast)
Cited by 0
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study
|The Lancet|2015|779
Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials
|The Lancet Diabetes & Endocrinology|2021|488